Beactica Therapeutics AB

Beactica Therapeutics AB is an SME in Uppsala, Sweden that has taken part in 11 EU-funded projects since 2008, receiving €4.4M in EU funding and leading 2 as coordinator.

EU funding received€4.4M
EU projects11
As coordinator2
Running now2
First EU project2008
Latest project2026
CountrySweden
EU registration (PIC)999676763
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Beactica Therapeutics AB's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€2.2M · 6 projects
  • Horizon Europe€1.6M · 2 projects
  • Horizon 2020€596k · 3 projects

Projects

11 EU-funded projects, newest first. Beactica Therapeutics AB led 2 of them as coordinator. Each links to the official record.

  • GLIOBREAKCoordinator

    Developing a new treatment and companion diagnostic to improve outcomes for glioblastoma patients

    Horizon Europe · 2026–2028 · Project on CORDIS ↗

    €1.6Mtheir share
  • SciLifeLab PULSEAssociated partner

    SciLifeLab Programme for fUture Leaders in life SciencE

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

  • UBIMOTIFPartner

    Short linear interaction motifs as specificity determinants in the ubiquitin system – discovery, mechanisms and therapeutic opportunities

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €282ktheir share
  • EpiGlioTCoordinator

    Epigenetic Glioblastoma Therapeutics

    Horizon 2020 · 2018–2018 · Project on CORDIS ↗

    €50ktheir share
  • FRAGNETPartner

    FRAGments training NETwork

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €264ktheir share
  • ENABLEPartner

    European Gram Negative Antibacterial Engine

    FP7 (2007 to 2013) · 2014–2020 · Project on CORDIS ↗

    €170ktheir share
  • FLUCUREPartner

    Development of novel antiviral drugs against Influenza

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €708ktheir share
  • SYNSYSPartner

    Synaptic Systems: dissecting brain function in health and disease

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €445ktheir share
  • BRAINTRAINPartner

    BrainTrain: Integrative neuroscience school on brain function and disease

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €215ktheir share
  • FLUDRUGSTRATEGYPartner

    Combating influenza using a novel drug strategy

    FP7 (2007 to 2013) · 2008–2010 · Project on CORDIS ↗

    €302ktheir share
  • NEUROCYPRESPartner

    Neurotransmitter Cys-loop receptors: structure, function and disease

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €355ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • antibiotic resistance
  • antibiotics
  • antivirals
  • clinical microbiology
  • computational science
  • coronaviruses
  • crystallography
  • drug discovery
  • employment
  • enzymes
  • epilepsy
  • genetics
  • genomes
  • immunotherapy

Beactica Therapeutics AB is listed on EUACC

See the startup profile for its product, team and what it is looking for.

Open the startup profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime